Lixte Biotechnology Holdings Inc (LIXT) — Cash Flow-to-Debt Ratio
Lixte Biotechnology Holdings Inc (LIXT) has a Cash Flow-to-Debt Ratio of -1.09x as of March 2026, meaning its operating cash flow of $-1.83 Million could theoretically repay -1% of its total liabilities ($1.69 Million) in one year. See financial flexibility index of Lixte Biotechnology Holdings Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Lixte Biotechnology Holdings Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Lixte Biotechnology Holdings Inc across 21 annual periods. For the full cash flow conversion analysis, see Lixte Biotechnology Holdings Inc (LIXT) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Lixte Biotechnology Holdings Inc (2005–2025)
Year-by-year debt coverage analysis for Lixte Biotechnology Holdings Inc. Check LIXT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.73x | $-3.07 Million | $1.77 Million | ▲ +82.6% |
| 2024 | -9.94x | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-443.45K | $124.50K | ▼ -35.5% |
| 2005 | -2.63x | $-32.87K | $12.50K | — |